Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 77 | 2024 | 6919 | 4.280 |
Why?
|
Microsatellite Instability | 20 | 2024 | 716 | 1.230 |
Why?
|
Fusobacterium nucleatum | 10 | 2024 | 176 | 1.120 |
Why?
|
Gastritis, Atrophic | 4 | 2009 | 32 | 0.770 |
Why?
|
Tumor Microenvironment | 16 | 2024 | 3875 | 0.750 |
Why?
|
DNA Mismatch Repair | 3 | 2024 | 428 | 0.750 |
Why?
|
Proto-Oncogene Proteins B-raf | 17 | 2024 | 2054 | 0.740 |
Why?
|
Mutation | 39 | 2024 | 30004 | 0.740 |
Why?
|
Alkylating Agents | 1 | 2021 | 133 | 0.730 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 11 | 2024 | 1089 | 0.730 |
Why?
|
CpG Islands | 10 | 2024 | 1190 | 0.620 |
Why?
|
Helicobacter pylori | 4 | 2009 | 382 | 0.590 |
Why?
|
Colonic Neoplasms | 8 | 2023 | 2527 | 0.570 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 12 | 2024 | 1746 | 0.550 |
Why?
|
DNA Methylation | 15 | 2024 | 4384 | 0.540 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2022 | 1892 | 0.500 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 955 | 0.480 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2022 | 2864 | 0.450 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2058 | 0.420 |
Why?
|
Bacteroides fragilis | 2 | 2024 | 250 | 0.410 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1658 | 0.370 |
Why?
|
Adenocarcinoma | 7 | 2023 | 6341 | 0.370 |
Why?
|
Oncogene Proteins | 1 | 2014 | 718 | 0.350 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3163 | 0.340 |
Why?
|
Metabolomics | 1 | 2019 | 1658 | 0.340 |
Why?
|
Stem Cells | 5 | 2024 | 3517 | 0.330 |
Why?
|
Fusobacterium Infections | 2 | 2021 | 53 | 0.330 |
Why?
|
Gastric Mucosa | 3 | 2009 | 603 | 0.330 |
Why?
|
Endometrial Neoplasms | 2 | 2016 | 1366 | 0.310 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4251 | 0.310 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5301 | 0.310 |
Why?
|
Humans | 109 | 2024 | 761222 | 0.280 |
Why?
|
Stomach Neoplasms | 4 | 2023 | 1457 | 0.280 |
Why?
|
Germ-Line Mutation | 8 | 2024 | 1852 | 0.270 |
Why?
|
Genomics | 8 | 2023 | 5829 | 0.250 |
Why?
|
DNA, Bacterial | 4 | 2018 | 1470 | 0.250 |
Why?
|
Pathology, Molecular | 2 | 2019 | 329 | 0.250 |
Why?
|
Gene Expression Profiling | 8 | 2020 | 9417 | 0.240 |
Why?
|
Melanoma | 2 | 2023 | 5694 | 0.240 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5366 | 0.240 |
Why?
|
Microsatellite Repeats | 2 | 2019 | 782 | 0.240 |
Why?
|
Immunotherapy | 5 | 2021 | 4642 | 0.240 |
Why?
|
DNA Copy Number Variations | 3 | 2024 | 2024 | 0.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2022 | 8531 | 0.220 |
Why?
|
Middle Aged | 43 | 2024 | 220858 | 0.210 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9567 | 0.210 |
Why?
|
Aged | 40 | 2024 | 169292 | 0.210 |
Why?
|
Neoplasms | 10 | 2024 | 22142 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1803 | 0.200 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1726 | 0.200 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 86 | 0.200 |
Why?
|
Biological Evolution | 1 | 2008 | 1075 | 0.200 |
Why?
|
Kynurenine | 2 | 2019 | 141 | 0.200 |
Why?
|
Metalloendopeptidases | 1 | 2024 | 389 | 0.200 |
Why?
|
Prospective Studies | 21 | 2024 | 54437 | 0.200 |
Why?
|
Asparaginase | 2 | 2020 | 239 | 0.190 |
Why?
|
Single-Cell Analysis | 4 | 2021 | 2452 | 0.190 |
Why?
|
Phenotype | 12 | 2024 | 16575 | 0.190 |
Why?
|
Keloid | 1 | 2022 | 55 | 0.190 |
Why?
|
DNA Glycosylases | 1 | 2022 | 124 | 0.190 |
Why?
|
Epithelium | 1 | 2006 | 1603 | 0.190 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
|
Lymphocytes | 3 | 2020 | 2603 | 0.180 |
Why?
|
Prognosis | 17 | 2024 | 29688 | 0.180 |
Why?
|
Loss of Heterozygosity | 2 | 2020 | 662 | 0.180 |
Why?
|
Female | 52 | 2024 | 392552 | 0.180 |
Why?
|
Genomic Islands | 1 | 2020 | 52 | 0.170 |
Why?
|
Carcinoma | 3 | 2016 | 2330 | 0.170 |
Why?
|
Cell Line, Tumor | 9 | 2022 | 16954 | 0.170 |
Why?
|
Cyclooxygenase 2 | 2 | 2020 | 597 | 0.170 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2024 | 899 | 0.170 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2020 | 87 | 0.170 |
Why?
|
Colon | 4 | 2020 | 1791 | 0.170 |
Why?
|
5'-Nucleotidase | 1 | 2020 | 161 | 0.160 |
Why?
|
Granulocytes | 1 | 2021 | 550 | 0.160 |
Why?
|
Spheroids, Cellular | 1 | 2021 | 329 | 0.160 |
Why?
|
Male | 45 | 2024 | 360703 | 0.160 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.160 |
Why?
|
Paraffin Embedding | 1 | 2020 | 302 | 0.160 |
Why?
|
Tissue Fixation | 1 | 2020 | 241 | 0.160 |
Why?
|
Diet | 5 | 2024 | 8048 | 0.160 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2023 | 380 | 0.160 |
Why?
|
Age of Onset | 2 | 2023 | 3307 | 0.160 |
Why?
|
Incidence | 8 | 2024 | 21366 | 0.150 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3594 | 0.150 |
Why?
|
Formaldehyde | 1 | 2020 | 357 | 0.150 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 322 | 0.150 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 518 | 0.150 |
Why?
|
Bifidobacterium | 1 | 2018 | 96 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6486 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 697 | 0.150 |
Why?
|
T-Lymphocytes | 5 | 2022 | 10203 | 0.150 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 82 | 0.150 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 610 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 4 | 2023 | 5665 | 0.150 |
Why?
|
Smad4 Protein | 1 | 2018 | 191 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 557 | 0.140 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2021 | 1351 | 0.140 |
Why?
|
Tryptophan | 1 | 2019 | 480 | 0.140 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39127 | 0.140 |
Why?
|
Folic Acid | 1 | 2024 | 1323 | 0.140 |
Why?
|
Coffee | 1 | 2022 | 593 | 0.140 |
Why?
|
Jews | 1 | 2019 | 356 | 0.140 |
Why?
|
Epithelial Cells | 2 | 2006 | 3671 | 0.140 |
Why?
|
Adult | 27 | 2024 | 221120 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2021 | 552 | 0.140 |
Why?
|
RNA-Binding Proteins | 2 | 2024 | 1855 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 710 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 280 | 0.130 |
Why?
|
Dietary Fiber | 1 | 2020 | 758 | 0.130 |
Why?
|
Immunohistochemistry | 5 | 2021 | 11067 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2019 | 4574 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2020 | 3634 | 0.130 |
Why?
|
Metabolome | 2 | 2020 | 989 | 0.130 |
Why?
|
Calcium, Dietary | 1 | 2019 | 529 | 0.130 |
Why?
|
Mutagenesis | 1 | 2020 | 1226 | 0.130 |
Why?
|
Inheritance Patterns | 1 | 2018 | 341 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1225 | 0.130 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.120 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2194 | 0.120 |
Why?
|
Pyrazines | 1 | 2021 | 1202 | 0.120 |
Why?
|
Medical History Taking | 1 | 2019 | 773 | 0.120 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 77 | 0.120 |
Why?
|
Adaptive Immunity | 2 | 2021 | 724 | 0.120 |
Why?
|
Tumor Escape | 1 | 2018 | 371 | 0.120 |
Why?
|
Monocytes | 2 | 2021 | 2570 | 0.120 |
Why?
|
Fruit | 1 | 2020 | 1158 | 0.120 |
Why?
|
Vegetables | 1 | 2020 | 1192 | 0.120 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3031 | 0.120 |
Why?
|
Escherichia coli | 3 | 2024 | 4201 | 0.120 |
Why?
|
Alcohol Drinking | 2 | 2024 | 4027 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 287 | 0.120 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.120 |
Why?
|
Peptides | 2 | 2024 | 4353 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 731 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 247 | 0.120 |
Why?
|
Cohort Studies | 10 | 2023 | 41496 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2023 | 11733 | 0.110 |
Why?
|
Helicobacter Infections | 2 | 2009 | 392 | 0.110 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 181 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 7 | 2024 | 17897 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1625 | 0.110 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3788 | 0.110 |
Why?
|
Medical Oncology | 2 | 2023 | 2320 | 0.110 |
Why?
|
Risk Factors | 14 | 2024 | 74241 | 0.100 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1301 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1605 | 0.100 |
Why?
|
Cell Differentiation | 3 | 2024 | 11512 | 0.100 |
Why?
|
Mice | 13 | 2024 | 81330 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2680 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 15920 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2022 | 3593 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2018 | 3512 | 0.100 |
Why?
|
Genome, Bacterial | 2 | 2008 | 785 | 0.100 |
Why?
|
Antineoplastic Agents | 5 | 2024 | 13632 | 0.100 |
Why?
|
Autophagy | 1 | 2020 | 1327 | 0.100 |
Why?
|
Oncogenes | 1 | 2017 | 1220 | 0.100 |
Why?
|
Sequence Analysis, DNA | 4 | 2017 | 4739 | 0.090 |
Why?
|
Cell Lineage | 1 | 2020 | 2549 | 0.090 |
Why?
|
Lymphocyte Count | 3 | 2020 | 781 | 0.090 |
Why?
|
Smoking | 3 | 2024 | 9055 | 0.090 |
Why?
|
Lung Neoplasms | 4 | 2022 | 13386 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3702 | 0.090 |
Why?
|
Precancerous Conditions | 1 | 2017 | 982 | 0.090 |
Why?
|
Transcription Factors | 4 | 2022 | 12101 | 0.090 |
Why?
|
Mice, Nude | 3 | 2022 | 3606 | 0.080 |
Why?
|
Logistic Models | 5 | 2024 | 13249 | 0.080 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 606 | 0.080 |
Why?
|
Colitis | 1 | 2018 | 1234 | 0.080 |
Why?
|
Germ Cells | 2 | 2024 | 632 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12676 | 0.080 |
Why?
|
Pyridines | 1 | 2021 | 2872 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7571 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2041 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1985 | 0.080 |
Why?
|
Animals | 14 | 2024 | 168089 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1882 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2024 | 22174 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 2016 | 1156 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2468 | 0.070 |
Why?
|
Sweden | 1 | 2009 | 1379 | 0.070 |
Why?
|
Genetic Variation | 1 | 2021 | 6567 | 0.060 |
Why?
|
Expressed Sequence Tags | 1 | 2006 | 250 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3129 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2770 | 0.060 |
Why?
|
Chronic Disease | 3 | 2009 | 9319 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11119 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8519 | 0.060 |
Why?
|
Quantitative Trait Loci | 2 | 2024 | 2113 | 0.060 |
Why?
|
Organoids | 2 | 2022 | 744 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Bacterial Adhesion | 1 | 2006 | 304 | 0.060 |
Why?
|
Rectum | 2 | 2019 | 891 | 0.060 |
Why?
|
Signal Transduction | 4 | 2024 | 23419 | 0.060 |
Why?
|
Bacteroides Infections | 1 | 2024 | 89 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5321 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5842 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.050 |
Why?
|
Gene Library | 1 | 2006 | 1054 | 0.050 |
Why?
|
Disease Progression | 4 | 2021 | 13511 | 0.050 |
Why?
|
Young Adult | 4 | 2023 | 59222 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2006 | 1989 | 0.050 |
Why?
|
Cell Separation | 1 | 2008 | 1721 | 0.050 |
Why?
|
DNA Damage | 2 | 2024 | 2443 | 0.050 |
Why?
|
Allelic Imbalance | 1 | 2022 | 77 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2024 | 64681 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12474 | 0.050 |
Why?
|
Lasers | 1 | 2006 | 952 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 185 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2021 | 317 | 0.050 |
Why?
|
Calmodulin | 1 | 2022 | 217 | 0.050 |
Why?
|
Body Size | 1 | 2024 | 463 | 0.050 |
Why?
|
Meat | 1 | 2024 | 584 | 0.050 |
Why?
|
Intention | 1 | 2024 | 347 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 383 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 180 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2023 | 6819 | 0.040 |
Why?
|
Hematoxylin | 1 | 2020 | 60 | 0.040 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 69 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9278 | 0.040 |
Why?
|
Albumins | 1 | 2023 | 575 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2023 | 385 | 0.040 |
Why?
|
Models, Genetic | 2 | 2021 | 3430 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 636 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12728 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2023 | 12747 | 0.040 |
Why?
|
Intestine, Small | 1 | 2006 | 1207 | 0.040 |
Why?
|
Bystander Effect | 1 | 2020 | 89 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2017 | 1741 | 0.040 |
Why?
|
Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2019 | 11 | 0.040 |
Why?
|
Consensus Sequence | 1 | 2020 | 362 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3758 | 0.040 |
Why?
|
Gene Amplification | 1 | 2024 | 1084 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 265 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2023 | 878 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2915 | 0.040 |
Why?
|
Asparagine | 1 | 2019 | 120 | 0.040 |
Why?
|
Edema | 1 | 2023 | 764 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2020 | 470 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 405 | 0.040 |
Why?
|
Sex Factors | 2 | 2024 | 10553 | 0.040 |
Why?
|
Genes, ras | 1 | 2021 | 654 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1070 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 103 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20588 | 0.040 |
Why?
|
Bacterial Toxins | 1 | 2024 | 923 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1010 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 734 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 17598 | 0.040 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2020 | 330 | 0.040 |
Why?
|
Endoscopy | 1 | 2008 | 1852 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1743 | 0.040 |
Why?
|
Genome | 1 | 2006 | 1738 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1490 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 552 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1032 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 470 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 809 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 956 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 329 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1822 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 634 | 0.030 |
Why?
|
United States | 6 | 2021 | 72341 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2813 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7865 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 822 | 0.030 |
Why?
|
Tumor Burden | 1 | 2022 | 1892 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1676 | 0.030 |
Why?
|
Epigenomics | 1 | 2022 | 944 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 2018 | 177 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 840 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 370 | 0.030 |
Why?
|
Gene Expression | 2 | 2022 | 7571 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2009 | 3836 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1334 | 0.030 |
Why?
|
Body Mass Index | 2 | 2024 | 12952 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1329 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1080 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1749 | 0.030 |
Why?
|
Paclitaxel | 1 | 2023 | 1730 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1111 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58952 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2778 | 0.030 |
Why?
|
Cell Line | 1 | 2009 | 15545 | 0.030 |
Why?
|
Isoenzymes | 1 | 2020 | 1682 | 0.030 |
Why?
|
Genetic Markers | 1 | 2021 | 2599 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1348 | 0.030 |
Why?
|
beta Catenin | 1 | 2020 | 1042 | 0.030 |
Why?
|
DNA Helicases | 1 | 2020 | 850 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1602 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 731 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2426 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2019 | 613 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1480 | 0.030 |
Why?
|
Age Factors | 2 | 2021 | 18384 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2022 | 10423 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 958 | 0.030 |
Why?
|
Computational Biology | 1 | 2006 | 3499 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2635 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1348 | 0.030 |
Why?
|
Fluorouracil | 1 | 2018 | 1642 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4107 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2553 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3390 | 0.030 |
Why?
|
Genotype | 2 | 2024 | 12985 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4015 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4618 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1743 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2022 | 2444 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2018 | 725 | 0.030 |
Why?
|
HLA Antigens | 1 | 2018 | 1331 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3590 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4243 | 0.020 |
Why?
|
Software | 1 | 2006 | 4431 | 0.020 |
Why?
|
Cell Survival | 1 | 2022 | 5778 | 0.020 |
Why?
|
Databases, Factual | 2 | 2019 | 7965 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 865 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2024 | 3410 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2897 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4513 | 0.020 |
Why?
|
Adenoma | 1 | 2021 | 2159 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 24022 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2816 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2598 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3337 | 0.020 |
Why?
|
Nurses | 1 | 2019 | 2477 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4111 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9458 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4243 | 0.020 |
Why?
|
Obesity | 2 | 2023 | 12940 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1038 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3577 | 0.020 |
Why?
|
Life Style | 1 | 2020 | 3907 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6857 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3763 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1589 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2809 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3552 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 4537 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80675 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4423 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 2517 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10756 | 0.020 |
Why?
|
Proteins | 1 | 2022 | 5993 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2270 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1448 | 0.020 |
Why?
|
Neurons | 1 | 2006 | 9429 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5755 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3198 | 0.020 |
Why?
|
Base Pairing | 1 | 2006 | 139 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10088 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5783 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15308 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4909 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18927 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3620 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20118 | 0.010 |
Why?
|
Critical Care | 1 | 2016 | 2696 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4310 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9652 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9478 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8642 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6417 | 0.010 |
Why?
|
Genomic Instability | 1 | 2006 | 709 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12052 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10759 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2006 | 2478 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14025 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26200 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 88300 | 0.010 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2006 | 1131 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6180 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29893 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6586 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36170 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9187 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39957 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3777 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42225 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10707 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26072 | 0.010 |
Why?
|
Child | 1 | 2020 | 80154 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20982 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18222 | 0.000 |
Why?
|